SignatureFD’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $160K | Buy |
700
+10
| +1% | +$2.24K | ﹤0.01% | 1114 |
|
|
2025
Q4 | $147K | Buy |
690
+8
| +1% | +$1.65K | ﹤0.01% | 1131 |
|
|
2025
Q3 | $136K | Buy |
682
+25
| +4% | +$4.66K | ﹤0.01% | 1136 |
|
|
2025
Q2 | $113K | Buy |
657
+17
| +3% | +$2.77K | ﹤0.01% | 1186 |
|
|
2025
Q1 | $99.8K | Sell |
640
-52
| -8% | -$7.43K | ﹤0.01% | 1215 |
|
|
2024
Q4 | $95.3K | Buy |
692
+6
| +0.9% | +$789 | ﹤0.01% | 1253 |
|
|
2024
Q3 | $102K | Buy |
686
+80
| +13% | +$10.8K | ﹤0.01% | 1207 |
|
|
2024
Q2 | $82.6K | Sell |
606
-46
| -7% | -$6.26K | ﹤0.01% | 1272 |
|
|
2024
Q1 | $98.6K | Buy |
652
+89
| +16% | +$12.7K | ﹤0.01% | 1198 |
|
|
2023
Q4 | $70.9K | Sell |
563
-235
| -29% | -$23.4K | ﹤0.01% | 1300 |
|
|
2023
Q3 | $74.7K | Buy |
798
+193
| +32% | +$18.1K | ﹤0.01% | 1203 |
|
|
2023
Q2 | $54K | Sell |
605
-672
| -53% | -$58.5K | ﹤0.01% | 1382 |
|
|
2023
Q1 | $137K | Sell |
1,277
-64
| -5% | -$7.32K | ﹤0.01% | 879 |
|
|
2022
Q4 | $164K | Buy |
1,341
+49
| +4% | +$5.69K | ﹤0.01% | 780 |
|
|
2022
Q3 | $133K | Buy |
1,292
+500
| +63% | +$47.4K | ﹤0.01% | 821 |
|
|
2022
Q2 | $74K | Buy |
792
+529
| +201% | +$49.9K | ﹤0.01% | 1112 |
|
|
2022
Q1 | $31K | Sell |
263
-393
| -60% | -$45.5K | ﹤0.01% | 1609 |
|
|
2021
Q4 | $88K | Sell |
656
-2
| -0.3% | -$297 | ﹤0.01% | 1079 |
|
|
2021
Q3 | $105K | Buy |
658
+176
| +37% | +$24.1K | ﹤0.01% | 946 |
|
|
2021
Q2 | $63K | Buy |
482
+125
| +35% | +$16.7K | ﹤0.01% | 1162 |
|
|
2021
Q1 | $46K | Buy |
357
+74
| +26% | +$11.2K | ﹤0.01% | 1203 |
|
|
2020
Q4 | $47K | Buy |
283
+61
| +27% | +$10.1K | ﹤0.01% | 1108 |
|
|
2020
Q3 | $34K | Buy |
222
+147
| +196% | +$21.1K | ﹤0.01% | 1139 |
|
|
2020
Q2 | $11K | Buy |
75
+43
| +134% | +$5.9K | ﹤0.01% | 1529 |
|
|
2020
Q1 | $4K | Buy |
+32
| New | +$4.16K | ﹤0.01% | 1718 |
|
Other funds holding ASND
RCM
ACA
